Sökning: WFRF:(Pedersen CB) >
Patients in complet...
-
Jakobsen, LHAalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
(författare)
Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark
- Artikel/kapitelEngelska2022
Förlag, utgivningsår, omfång ...
-
2022-01-27
-
Springer Science and Business Media LLC,2022
Nummerbeteckningar
-
LIBRIS-ID:oai:prod.swepub.kib.ki.se:148708776
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:148708776URI
-
https://doi.org/10.1038/s41408-022-00614-8DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-467456URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
For most patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), R-CHOP immunochemotherapy leads to complete remission and 60–70% of patients remain progression-free after 5 years. Given a median age of 65, it is relevant to disentangle how DLBCL and DLBCL therapy influence health care use among the survivors. In this nationwide study, the health care use among Danish DLBCL patients diagnosed in 2007–2015, who achieved complete remission after R-CHOP(-like) therapy, was explored and compared to matched comparators from the Danish general population. The post-remission 5-year risk of hospitalization was significantly higher among DLBCL survivors (55%) compared to matched comparators (49%, P < 0.001). DLBCL survivors had on average 10.3 (9.3–11.3) inpatient bed days within 5 years of response evaluation, whereas matched comparators had 8.4 (7.9–8.8). The rate of outpatient visits was also significantly higher(excluding routine follow-up visits, incidence rate ratio, 1.3, P < 0.001), but translated into only a very small absolute difference of <1 outpatient visits within 5 years between DLBCL survivors (4.2 visits, 95% CI, 4.0–4.4) and matched comparators (3.8 visits, 95% CI, 3.7–3.9). In conclusion, DLBCL survivors have an increased incidence of hospital visits due to a wide range of conditions, but in absolute terms the excess use of health care services in DLBCL survivors was small.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Ovlisen, AKAalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
(författare)
-
Severinsen, MTAalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
(författare)
-
Baech, JAalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.
(författare)
-
Kragholm, KHAalborg Univ Hosp, Unit Clin Biostat & Epidemiol, Aalborg, Denmark.;Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.
(författare)
-
Glimelius, Ingrid,1975-Uppsala universitet,Karolinska Institutet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden.(Swepub:uu)inggl846
(författare)
-
Gang, AORigshosp, Dept Hematol, Copenhagen, Denmark.
(författare)
-
Jorgensen, JMAarhus Univ Hosp, Dept Hematol, Aarhus, Denmark.
(författare)
-
Frederiksen, HOdense Univ Hosp, Dept Hematol, Odense, Denmark.
(författare)
-
Poulsen, CBZealand Univ Hosp, Dept Hematol, Roskilde, Denmark.
(författare)
-
Clausen, MRVejle Sygehus, Dept Hematol, Vejle, Denmark.
(författare)
-
Pedersen, PTSydvestjysk Sygehus, Dept Hematol, Esbjerg, Denmark.,Nordsjaellands Hosp, Dept Cardiol, Hillerod, Denmark.;Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
(författare)
-
Pedersen, RSHolstebro Sygehus, Dept Med, Holstebro, Denmark.
(författare)
-
Torp-Pedersen, C
(författare)
-
Eloranta, SKarolinska Institutet,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden.
(författare)
-
El-Galaly, TCKarolinska Institutet,Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.
(författare)
-
Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.;Aalborg Univ, Dept Clin Med, Aalborg, Denmark.Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Hematol, Aalborg, Denmark.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Blood cancer journal: Springer Science and Business Media LLC12:1, s. 16-2044-5385
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Jakobsen, LH
-
Ovlisen, AK
-
Severinsen, MT
-
Baech, J
-
Kragholm, KH
-
Glimelius, Ingri ...
-
visa fler...
-
Gang, AO
-
Jorgensen, JM
-
Frederiksen, H
-
Poulsen, CB
-
Clausen, MR
-
Pedersen, PT
-
Pedersen, RS
-
Torp-Pedersen, C
-
Eloranta, S
-
El-Galaly, TC
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Blood cancer jou ...
- Av lärosätet
-
Karolinska Institutet
-
Uppsala universitet